Sotalol oral solution - Arbor Pharmaceuticals
Alternative Names: AR05; Sotalol hydrochloride oral solution - Arbor Pharmaceuticals; SotylizeLatest Information Update: 26 May 2022
At a glance
- Originator Arbor Pharmaceuticals
- Class Antihypertensives; Class III antiarrhythmics; Ethanolamines
- Mechanism of Action Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Atrial fibrillation; Atrial flutter; Ventricular arrhythmias
Most Recent Events
- 23 Oct 2014 Registered for Atrial fibrillation in USA (PO)
- 23 Oct 2014 Registered for Atrial flutter in USA (PO)
- 23 Oct 2014 Registered for Ventricular arrhythmias in USA (PO) - First global approval